• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.

作者信息

Adams G E, Stratford I J

出版信息

Biochem Pharmacol. 1986 Jan 1;35(1):71-6. doi: 10.1016/0006-2952(86)90560-5.

DOI:10.1016/0006-2952(86)90560-5
PMID:2934067
Abstract
摘要

相似文献

1
Hypoxia-mediated nitro-heterocyclic drugs in the radio- and chemotherapy of cancer. An overview.缺氧介导的硝基杂环药物在癌症放疗和化疗中的应用。综述
Biochem Pharmacol. 1986 Jan 1;35(1):71-6. doi: 10.1016/0006-2952(86)90560-5.
2
Ro-07-0582 as a radiosensitizer and cytotoxic agent.
Int J Radiat Oncol Biol Phys. 1977 May-Jun;2(5-6):521-30. doi: 10.1016/0360-3016(77)90163-8.
3
Differential cytotoxic effects of metronidazole and other nitro-heterocyclic drugs against hypoxic tumour cells.甲硝唑及其他硝基杂环药物对缺氧肿瘤细胞的细胞毒性差异作用。
Int J Radiat Oncol Biol Phys. 1978 Jan-Feb;4(1-2):153-6. doi: 10.1016/0360-3016(78)90131-1.
4
Sensitizers and protectors in clinical oncology.临床肿瘤学中的致敏剂和保护剂。
Semin Oncol. 1981 Mar;8(1):65-82.
5
Chemosensitization in vitro: potentiation of melphalan toxicity by misonidazole, metronidazole and nitrofurazone.体外化学增敏作用：米索硝唑、甲硝唑和呋喃西林增强美法仑的毒性
Int J Radiat Oncol Biol Phys. 1982 Mar-Apr;8(3-4):615-7. doi: 10.1016/0360-3016(82)90696-4.
6
Testing of hypoxic cell radiosensitizers in vivo.体内缺氧细胞放射增敏剂的测试。
Cancer Clin Trials. 1980 Summer;3(2):139-48.
7
Radiosensitization by a new nucleoside analogue: 1-[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl-2-nitroimidazole (RP-170).一种新型核苷类似物1-[2-羟基-1-(羟甲基)乙氧基]甲基-2-硝基咪唑（RP-170）的放射增敏作用
Int J Radiat Oncol Biol Phys. 1989 Sep;17(3):575-81. doi: 10.1016/0360-3016(89)90109-0.
8
The biological properties of reduced nitroheterocyclics and possible underlying biochemical mechanisms.还原型硝基杂环化合物的生物学特性及潜在的生化机制。
Biochem Pharmacol. 1986 Jan 1;35(1):97-103. doi: 10.1016/0006-2952(86)90565-4.
9
The use of nitroaromatic compounds as hypoxic cell radiosensitizers.硝基芳香化合物作为低氧细胞放射增敏剂的应用。
Curr Top Radiat Res Q. 1977 Aug;11(4):347-98.
10
[Present status of radiation sensitizers--hypoxic cell radiosensitizer].辐射增敏剂的现状——乏氧细胞放射增敏剂
Gan To Kagaku Ryoho. 1989 Jun;16(6):2135-41.

引用本文的文献

1
Effect of post-implant exercise on tumour growth rate, perfusion and hypoxia in mice.植入后运动对小鼠肿瘤生长速率、灌注和缺氧的影响。
PLoS One. 2020 Mar 18;15(3):e0229290. doi: 10.1371/journal.pone.0229290. eCollection 2020.
2
Ethyl 3-oxo-2-(2,5-dioxopyrrolidin-3-yl)butanoate Derivatives: Anthelmintic and Cytotoxic Potentials, Antimicrobial, and Docking Studies.3-氧代-2-(2,5-二氧代吡咯烷-3-基)丁酸乙酯衍生物：驱虫和细胞毒性潜力、抗菌及对接研究
Front Chem. 2017 Dec 12;5:119. doi: 10.3389/fchem.2017.00119. eCollection 2017.
3
Synthesis and Biological Evaluation of Iodoglucoazomycin (I-GAZ), an Azomycin-Glucose Adduct with Putative Applications in Diagnostic Imaging and Radiotherapy of Hypoxic Tumors.
碘葡糖偶氮霉素（I-GAZ）的合成与生物学评价，一种偶氮霉素-葡萄糖加合物，在缺氧肿瘤的诊断成像和放射治疗中具有潜在应用。
ChemMedChem. 2016 Aug 5;11(15):1638-45. doi: 10.1002/cmdc.201600213. Epub 2016 Jul 5.
4
Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases.使用动态对比增强磁共振成像和18F-氟米索硝唑正电子发射断层扫描成像对颈部淋巴结转移瘤的肿瘤微环境进行无创评估。
Int J Radiat Oncol Biol Phys. 2010 Aug 1;77(5):1403-10. doi: 10.1016/j.ijrobp.2009.07.009. Epub 2009 Nov 10.
5
Fluorine-18-labeled fluoromisonidazole positron emission and computed tomography-guided intensity-modulated radiotherapy for head and neck cancer: a feasibility study.氟-18标记的氟米索硝唑正电子发射断层扫描与计算机断层扫描引导的调强放射治疗用于头颈癌：一项可行性研究。
Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):2-13. doi: 10.1016/j.ijrobp.2007.06.039. Epub 2007 Sep 14.
6
Does reductive metabolism predict response to tirapazamine (SR 4233) in human non-small-cell lung cancer cell lines?还原代谢能否预测人非小细胞肺癌细胞系对替拉扎明（SR 4233）的反应？
Br J Cancer. 1999 Dec;81(7):1127-33. doi: 10.1038/sj.bjc.6690819.
7
Solubility behavior, phase transition, and structure-based nucleation inhibition of etanidazole in aqueous solutions.
Pharm Res. 1996 Sep;13(9):1401-5. doi: 10.1023/a:1016038403921.
8
Phase I/pharmacokinetic/biochemical study of the nitroimadazole hypoxic cell sensitiser SR2508 (etanidazole) in combination with cyclophosphamide.硝基咪唑类乏氧细胞增敏剂SR2508（依他硝唑）与环磷酰胺联合应用的I期/药代动力学/生化研究
Br J Cancer. 1993 Oct;68(4):756-66. doi: 10.1038/bjc.1993.424.
9
Importance of P450 reductase activity in determining sensitivity of breast tumour cells to the bioreductive drug, tirapazamine (SR 4233).细胞色素P450还原酶活性在决定乳腺肿瘤细胞对生物还原药物替拉扎明（SR 4233）敏感性中的重要性。
Br J Cancer. 1995 Nov;72(5):1144-50. doi: 10.1038/bjc.1995.478.
10
Characterization of radiation resistant hypoxic cell subpopulations in KHT sarcomas. (II). Cell sorting.KHT肉瘤中耐辐射缺氧细胞亚群的特征分析。（II）细胞分选。
Br J Cancer. 1988 Sep;58(3):296-300. doi: 10.1038/bjc.1988.207.